Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for HIV-1-infected virologically suppressed patients: results from the randomized non-inferiority MONCAY trial

L. Hocqueloux,C. Allavena,T. Prazuck,L. Bernard,S. Sunder, J. -L. Esnault,D. Rey,G. Le Moal, M. Roncato-Saberan, M. Andre,E. Billaud,V. Avettand-Fenoel, A. Valery, F. Raffi,J. -J. Parienti

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2018)

引用 13|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要